Literature DB >> 21206877

Merits of EEG monitoring during ect: a prospective study on 485 patients.

K Girish1, B N Gangadhar, N Janakiramaiah.   

Abstract

Eliciting cerebral seizure during electroconvulsive therapy (ECT) is essential for therapeutic purposes. When it exceeds beyond 120 seconds (Freeman, 1995) i.e., prolonged, it adds to adverse effects of ECT. Estimating seizure duration using 'cuff method' alone has limitations. This study examined the merits of electroencephalographic (EEG) monitoring in routine ECT practice on a large representative sample. Modified ECT either unilateral or bilateral electrode placement, was administered to 485 patients under EEG monitoring at first ECT session. Ninety one (18.8%) patients had prolonged seizures of which only 59 would have been detected if 'cuff method' alone was used. Twenty nine (6%) patients had inadequate motor seizures but had adequate EEG seizure duration. Twenty five (5.2%) of them had no motor seizure and two such patients even had prolonged seizures. The prolonged seizure was unpredictable in majority. In conclusion, EEG monitoring during ECT is essential to detect both adequacy of cerebral seizure in patients having no or inadequate motor seizures and a/so to detect prolonged seizures.

Entities:  

Keywords:  EEG monitoring; electroconvulsive therapy prolonged seizure

Year:  2002        PMID: 21206877      PMCID: PMC2953649     

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


  11 in total

1.  Use of succinylcholine in E.C.T., with particular reference to its effect on blood pressure.

Authors:  D J ADDERLEY; M HAMILTON
Journal:  Br Med J       Date:  1953-01-24

2.  Problems with lithium combined with ECT.

Authors:  V Milstein; J G Small
Journal:  Am J Psychiatry       Date:  1988-09       Impact factor: 18.112

Review 3.  Motor versus EEG seizure duration in ECT.

Authors:  E H Liston; B H Guze; L R Baxter; S H Richeimer; M E Gold
Journal:  Biol Psychiatry       Date:  1988-05       Impact factor: 13.382

4.  Motor seizure monitoring during electroconvulsive therapy.

Authors:  P M Mayur; B N Gangadhar; N Janakiramaiah; D K Subbakrishna
Journal:  Br J Psychiatry       Date:  1999-03       Impact factor: 9.319

5.  Detection of Prolonged Seizures During Electroconvulsive Therapy: A Comparison of Electroencephalogram and Cuff Monitoring.

Authors:  Lawrence B. Greenberg
Journal:  Convuls Ther       Date:  1985

6.  The effects of ECT stimulus dose and electrode placement on the ictal electroencephalogram: an intraindividual crossover study.

Authors:  A D Krystal; R D Weiner; W V McCall; F E Shelp; R Arias; P Smith
Journal:  Biol Psychiatry       Date:  1993-12-01       Impact factor: 13.382

7.  Factors affecting amnesia, seizure duration, and efficacy in ECT.

Authors:  A L Miller; R A Faber; J P Hatch; H E Alexander
Journal:  Am J Psychiatry       Date:  1985-06       Impact factor: 18.112

Review 8.  The monitoring and management of electrically induced seizures.

Authors:  R D Weiner; C E Coffey; A D Krystal
Journal:  Psychiatr Clin North Am       Date:  1991-12

Review 9.  Generalized nonconvulsive status epilepticus after electroconvulsive therapy.

Authors:  R Grogan; D R Wagner; T Sullivan; D Labar
Journal:  Convuls Ther       Date:  1995-03

10.  Monitoring the duration of electroconvulsive therapy seizures: 'cuff' and EEG methods compared.

Authors:  M Fink; L Johnson
Journal:  Arch Gen Psychiatry       Date:  1982-10
View more
  2 in total

1.  Research on electroconvulsive therapy in India: An overview.

Authors:  Bangalore N Gangadhar; Vivek H Phutane; Jagadisha Thirthalli
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

Review 2.  Two decades of an indigenously developed brief-pulse electroconvulsive therapy device: A review of research work from National Institute of Mental Health and Neurosciences.

Authors:  Preeti Sinha; A ShyamSundar; Jagadisha Thirthalli; B N Gangadhar; Vittal S Candade
Journal:  Indian J Psychiatry       Date:  2016 Jan-Mar       Impact factor: 1.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.